Adenovirus-mediated p53 gene transfer suppresses growth of human glioblastoma cells in vitro and in vivo

International Journal of Cancer

Volumn 67, Issue 6, 1996, Pages 808-815

  Köck, Helge ^a   Harris, Matthew P ^b   Anderson, Scott C ^b   Machemer, Todd ^b   Hancock, Wendy ^b   Sutjipto, Suganto ^b   Wills, Ken N ^b   Gregory, Richard J ^b   Shepard, H Michael ^b   Westphal, Manfred ^a   Maneval, Daniel C ^b  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

ADENOVIRUS; ARTICLE; CONTROLLED STUDY; GENE THERAPY; GENE TRANSFER; GLIOBLASTOMA; GROWTH INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; TUMOR CELL LINE; VIRUS RECOMBINANT;

ADENOVIRIDAE; ANIMALS; APOPTOSIS; CELL DIVISION; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENES, P53; GLIOBLASTOMA; HUMANS; L-LACTATE DEHYDROGENASE; MICE; MICE, INBRED BALB C; MICE, NUDE; RATS; TUMOR CELLS, CULTURED;

EID: 10244234032     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19960917)67:6<808::AID-IJC9>3.0.CO;2-V     Document Type: Article

References (44)

1. AKLI, S., CAILLAUD, C., VIGNE, E., STRATFORD-PERRICAUDET, L.D., POENARU, L., PERRICAUDET, M., KAHN, A. and PESCHANSKI, M.R., Transfer of a foreign gene into the brain using adenovirus vectors. Nature (Genet.), 3, 224-228 (1993).
2. Au, I.U., SCHWEITZER, J.B., IKEJIRI, B., SAXENA, A., ROBERTSON, J.T. and OLDFIELD, E.H., Heterogeneity of subcellular localization of p53 protein in human glioblastomas. Cancer Res., 54, 1-5 (1994).
3. AMMIRATI, M., GALICICH, J.H., ARBIT, E. and LIAO, Y., Reoperation in the treatment of recurrent intracranial malignant gliomas. Neurosurgery, 21, 607-614 (1987).
4. ANKER, L., OHGAKI, H., LUDEKE, B.I., HERRMANN, H.-D., KLEIHULS, P. and WESTPHAL. M., p53 protein accumulation and gene mutations in human glioma cell lines. Int. J. Cancer, 55, 982-987 (1993).
5. BADIE, B., DRAZAN, K.E., KRAMAR, M.H., SHAKED, A. and BLACK, K.L., Adenovirus-mediated p53 gene delivery inhibits 9L glioma growth in rats. Neural. Res., 17, 209-216 (1995).
6. BAJOCCHI, G., FELDMAN, S.H., CRYSTAL, R.G. and MASTRANGELI, A., Direct in vivo gene transfer to ependymal cells in the central nervous system using recombinant adenovirus vectors. Nature (Genet.), 3, 229-234 (1993).
7. CAI, D.W., MUKHOPADHYAY, T., LIU, Y., FUJIWARA, T. and ROTH, J.A., Stable expression of the wild-type p53 gene in human lung cancer cells after retrovirus-mediated gene transfer. Hum. Gene Ther., 4, 617-624 (1993).
8. CHEN, P.-L., CHEN, Y., BOOKSTEIN, R. and LEE, W.-H., Genetic mechanisms of tumor suppression by the human p53 gene. Science, 250, 1576-1580 (1990).
9. CHEN, S.-H., SHINE, H.D., GOODMAN, J.C., GROSSMAN, R.G. and Woo, S.L.C., Gene therapy for brain tumors: regression of experimental gliomas by adenovirus-mediated gene transfer in vivo. Proc. nat. Acad. Sci. (Wash.), 91, 3054-3057 (1994).
10. CHUNG, R., WHALEY, J., KLEY, N., ANDERSON, K., LOUIS, D., MENON, A., HETTLICH, C., FREIMAN, R., HEDLEY-WHYTE, E.T., MARTURZA, R., JENKINS, R., YANDELL, D. and SEIZINGER, B.R., TP53 gene mutations and 17p deletions in human astrocytomas. Genes, Chromosomes Cancer, 3, 323-331 (1991).
11. CRYSTAL, R.G., Transfer of gene to humans: early lessons and obstacles to success. Science, 270, 404-410 (1995).
12. CULVER, K.W., RAM, Z., WALLBRIDGE, S., ISHIJ, H., OLDFIELD, E.H. and BLAESE, R.M., In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors. Science, 256, 1550-1552 (1992).
13. DAVIDSON, B.L., ALLEN, E.D., KOZARSKY, K.F., WILSON, J.M. and ROESSLER, B.J., A model system for in vivo gene transfer into the central nervous system using an adenoviral vector. Nature (Genet.), 3, 221-223 (1993).
14. DORAN, S.E., REN, X.D., BETZ, A.L., PAGEL, M.A., NEUWELT, E.A., ROESSLER, B.J. and DAVIDSON, B.L., Gene expression from recombinant viral vectors in the central nervous system after blood-brain barrier disruption. Neurosurgery, 36, 965-970 (1995).
15. DORAN, S.E., ROESSLER, B.J., HARTMAN, J.W., HOFF, J.T., SHEWACH, D.S. and DAVIDSON, B.L., Adenovirus-mediated in vivo gene transfer into the central nervous system of a non-human primate. Clin. Neurosurg., 41, 242-257 (1993).
16. FUJIWARA, T., GRIMM, E.A., MUKHOPADHYAY, T., ZHANG, W.-W., OWEN-SCHAUB, L.B. and ROTH, J.A., Induction of chemosensitivity in human lung cancer cells in vivo by adenovirus-mediated transfer of the wild-type p53 gene. Cancer Res., 54, 2287-2291 (1994).
17. FULTS, D., BROCKMEYER, D., TULLOUS, M.W., PEDONE, C.A. and CAWTHON, R.M., p53 mutation and loss of heterozygosity on chromosomes 17 and 10 during human astrocytoma progression. Cancer Res., 52, 674-679 (1992).
18. GREENBLATT, M.S., BENNETT, W.P., HOLLSTEIN, M. and HARRIS, C.C., Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res., 54, 4855-4878 (1994).
19. HARRIS, C.C. and HOLLSTEIN, M., Clinical implications of the p53 tumor-suppressor gene. New Engl. J. Med., 329, 1318-1327 (1993).
20. HARRIS, M.P., SUTJIPTO, S., WILLS, K.M., HANCOCK, W., CORNELL, D., JOHNSON, D.E., GREGORY, R.J., SHEPARD, H.M. and MANEVAL, D.C., Adenovirus-mediated p53 gene transfer inhibits growth of human tumor cells expressing mutant p53 protein. Cancer Gene Ther., 3, 121-130 (1996).
21. HAYASHI, Y., YAMASHITA, J. and YAMAGUCHI, K., Timing and role of p53 gene mutation in the recurrence of glioma. Biochem. biophys. Res. Comm., 180, 1145-1150 (1991).
22. HIRSCHOWITZ, E.A., OHWADA, A., PASCAL, W.R., RUSSI, T.J. and CRYSTAL, R.G., In vivo adenovirus-mediated gene transfer of the Escherichia coli cytosine deaminase gene to human colon carcinoma-derived tumors induces chemosensitivity to 5-ftuorocytosine. Hum. Gene Ther., 6, 1055-1063 (1995).
23. HUYGHE, B.G., LIU, X., SUTJIPTO, S., SUGARMAN, B.J., HORN, M.T., SHEPARD, H.M., SCANDELLA, C.J. and SHABRAM, P., Purification of a type 5 recombinant adenovirus encoding human p53 by column chromatography. Hum. Gene Ther., 6, 1403-1416 (1995).
24. KORZENIEWSKI, C. and CALLEWAERT, D.M., An enzyme-release assay for natural cytotoxicity. Immunol. Methods, 64, 313-320 (1983).
25. LANE, D.P., LU, X., HUPP, T. and HALL, P.A., The role of p53 in the apoptotic response. Phil. Trans. Roy. Soc. Lond. B., 345, 277-280 (1994).
26. LEVINE, A.J., MOMAND, J. and FINLAY, C.A., The p53 tumour suppressor gene. Nature (Lond.), 351, 453-456 (1991).
27. LOUIS, D.N., The p53 gene and protein in human brain tumors. J. Neuropathol. exp. Neurol., 53, 11-21 (1994).
28. MALKIN, D., p53 and the Li-Fraumeni syndrome. Cancer Genet. Cytogenet., 66, 83-92 (1993).
29. MERCER, W.E., SHIELDS, M.T., AMIN, M., SAUVE, G.J., APPELLA, E., ROMANO, J.W. and ULLRICH, S.J., Negative growth regulation in a glioblastoma tumor cell line that conditionally expresses human wild-type p53. Proc. nat. Acad. Sci. (Wash.), 87, 6166-6170 (1990).
30. MERZAK, A., RAYNAL, S., ROGERS, J.P., LAWRENCE, D. and PILKINGTON, G.J., Human wild-type p53 inhibits cell proliferation and elicits dramatic morphological changes in human glioma cell lines in vitro. J. neural. Sci., 127, 125-133 (1994).
31. REIFENBERGER, G., LIU, L., ICHIMURA, K., SCHMIDT, E.E. and COLLINS, V.P., Amplification and overexpression of the MDM2 gene in a subset of human malignant gliomas without p53 mutations. Cancer Res., 53, 2736-2739 (1993).
32. SALLE, G.L., ROBERT, J.J., BERRARD, S., RIDOUX, V., STRATFORD-PERRICAUDET, L.D., PERRICAUDET, M. and MALLET, J., An adenovirus vector for gene transfer into neurons and glia in the brain. Science, 259, 988-990 (1993).
33. SHAW, P., BOVEY, R., TARDY, S., SAHLI, R., SORDAT, B. and COSTA, J., Induction of apoptosis by wild-type p53 in a human colon tumor-derived cell line. Proc. nat. Acad. Sci. (Wash.), 89, 4495-4499 (1992).
34. SIDRANSKI, D., MIKKELSEN, T., SCHWECHHEIMER, K., ROSENBLUM, M.L., CAVENEE, W. and VOGELSTEIN, B., Clonal expansion of p53 mutant cells is associated with brain tumour progression. Nature (Lond.), 355, 846-847 (1992).
35. SOBOL, R.E., FAKHRAI, H., SHAWLER, D., GJERSET, R., DORIGO, O., CARSON, C., KHALEGHI, T., KOZIOL, J., SHIFTAN, T.A. and ROYSTON, I., Interleukin-2 gene therapy in a patient with glioblastoma. Gene Ther., 2, 164-167 (1995).
36. SYMONDS, H., KRALL, L., REMINGTON, L., SAENZ-ROBLES, M., LOWE, S., JACKS, T. and DYKE, T.V., p53-dependent apoptosis suppresses tumor growth and progression in vivo. Cell, 78, 703-711 (1994).
37. TRAPNELL, B.C., Adenoviral vectors for gene transfer. Adv. Drug Delivery Rev., 12, 185-199 (1993).
38. VAN MEIR, E.G., KIKUCHI, T., TADA, M., LI, H., DISERENS, A.-C., WOJCIK, B.E., HUANG, H.-J.S., FRIEDMANN, T., DE TRIBOLET, N. and CAVENEE, W.K., Analysis of the p53 gene and its expression in human glioblastoma cells. Cancer Res., 54, 649-652 (1994a).
39. VAN MEIR, E.G., POLVERINI, P.J., CHAZIN, V.R., HUANG, H.-J.S., DE TRIBOLET, N. and CAVENEE, W.K., Release of an inhibitor of angiogenesis upon induction of wild type p53 expression in glioblastoma cells. Nature (Genet.), 8, 171-176 (1994b).
40. VOGELSTEIN, B. and KINZLER, K.W., p53 function and dysfunction. Cell, 70, 523-526 (1992).
41. WALKER, P.R., KOKILEVA, L., LEBLANC, J. and SIKORSKA, M., Detection of the initial stages of DNA fragmentation in apoptosis. BioTechniques, 15, 1032-1040 (1993).
42. WESTPHAL, M., HANSEL, M., HAMEL, W., KUNZMANN, R. and HOLZEL, F., Karyotype analyses of 20 human glioma cell lines. Acta neurochir., 126, 17-26 (1994).
43. WILLS, K.N. and 12 OTHERS, Development and characterization of recombinant adenoviruses encoding p53 for gene therapy of cancer. Hum. Gene Ther., 5, 1079-1088 (1994).
44. YAHANDA, A.M., BRUNER, J.M., DONEHOWER, L.A. and MORRISON, R.S., Astrocytes derived from p53-deficient mice provide a multistep in vitro model for development of malignant gliomas. Mol. cell. Biol., 15, 4249-4259 (1995).